United States OTC Drug Market Report 2016

Publisher Name :
Date: 02-Sep-2016
No. of pages: 116
Inquire Before Buying

Notes:

Sales, means the sales volume of OTC Drug

Revenue, means the sales value of OTC Drug

This report studies sales (consumption) of OTC Drug in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Bayer HealthCare

- GlaxoSmithKline (GSK)

- Johnson & Johnson

- Pfizer

- Sanofi

- AstraZeneca

- BioGaia

- Bristol Myers Squibb

- Bukwang Pharmaceutica

- Chr. Hansen

- Cipla

- CoLucid

- Daiichi Sankyo

- Dr. Reddy's Laboratories

- DSM

- Eisai

- Eli Lilly

- EMS

- Euradite

- Friggs

- Genomma Lab Internacional

- Glanbia

- Herbalife

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of OTC Drug in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States OTC Drug Market Report 2016

Table of Contents
United States OTC Drug Market Report 2016
1 OTC Drug Overview
1.1 Product Overview and Scope of OTC Drug
1.2 Classification of OTC Drug
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of OTC Drug
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 USA Market Size Sales (Value) and Revenue (Volume) of OTC Drug (2011-2021)
1.4.1 USA OTC Drug Sales and Growth Rate (2011-2021)
1.4.2 USA OTC Drug Revenue and Growth Rate (2011-2021)
2 USA OTC Drug Competition by Manufacturers
2.1 USA OTC Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA OTC Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 USA OTC Drug Average Price by Manufactures (2015 and 2016)
2.4 OTC Drug Market Competitive Situation and Trends
2.4.1 OTC Drug Market Concentration Rate
2.4.2 OTC Drug Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 USA OTC Drug Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 USA OTC Drug Sales and Market Share by Type (2011-2016)
3.2 USA OTC Drug Revenue and Market Share by Type (2011-2016)
3.3 USA OTC Drug Price by Type (2011-2016)
3.4 USA OTC Drug Sales Growth Rate by Type (2011-2016)
4 USA OTC Drug Sales (Volume) by Application (2011-2016)
4.1 USA OTC Drug Sales and Market Share by Application (2011-2016)
4.2 USA OTC Drug Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 USA OTC Drug Manufacturers Profiles/Analysis
5.1 Bayer HealthCare
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 OTC Drug Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Bayer HealthCare OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 GlaxoSmithKline (GSK)
5.2.2 OTC Drug Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 GlaxoSmithKline (GSK) OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Johnson & Johnson
5.3.2 OTC Drug Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Johnson & Johnson OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Pfizer
5.4.2 OTC Drug Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Pfizer OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Sanofi
5.5.2 OTC Drug Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Sanofi OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 AstraZeneca
5.6.2 OTC Drug Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 AstraZeneca OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 BioGaia
5.7.2 OTC Drug Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 BioGaia OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Bristol Myers Squibb
5.8.2 OTC Drug Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Bristol Myers Squibb OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Bukwang Pharmaceutica
5.9.2 OTC Drug Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Bukwang Pharmaceutica OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Chr. Hansen
5.10.2 OTC Drug Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Chr. Hansen OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Cipla
5.12 CoLucid
5.13 Daiichi Sankyo
5.14 Dr. Reddy's Laboratories
5.15 DSM
5.16 Eisai
5.17 Eli Lilly
5.18 EMS
5.19 Euradite
5.20 Friggs
5.21 Genomma Lab Internacional
5.22 Glanbia
5.23 Herbalife
6 OTC Drug Manufacturing Cost Analysis
6.1 OTC Drug Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of OTC Drug
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 OTC Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of OTC Drug Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 USA OTC Drug Market Forecast (2016-2021)
10.1 USA OTC Drug Sales, Revenue Forecast (2016-2021)
10.2 USA OTC Drug Sales Forecast by Type (2016-2021)
10.3 USA OTC Drug Sales Forecast by Application (2016-2021)
10.4 OTC Drug Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of OTC Drug
Table Classification of OTC Drug
Figure USA Sales Market Share of OTC Drug by Type in 2015
Table Application of OTC Drug
Figure USA Sales Market Share of OTC Drug by Application in 2015
Figure USA OTC Drug Sales and Growth Rate (2011-2021)
Figure USA OTC Drug Revenue and Growth Rate (2011-2021)
Table USA OTC Drug Sales of Key Manufacturers (2015 and 2016)
Table USA OTC Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 OTC Drug Sales Share by Manufacturers
Figure 2016 OTC Drug Sales Share by Manufacturers
Table USA OTC Drug Revenue by Manufacturers (2015 and 2016)
Table USA OTC Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA OTC Drug Revenue Share by Manufacturers
Table 2016 USA OTC Drug Revenue Share by Manufacturers
Table USA Market OTC Drug Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market OTC Drug Average Price of Key Manufacturers in 2015
Figure OTC Drug Market Share of Top 3 Manufacturers
Figure OTC Drug Market Share of Top 5 Manufacturers
Table USA OTC Drug Sales by Type (2011-2016)
Table USA OTC Drug Sales Share by Type (2011-2016)
Figure USA OTC Drug Sales Market Share by Type in 2015
Table USA OTC Drug Revenue and Market Share by Type (2011-2016)
Table USA OTC Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of OTC Drug by Type (2011-2016)
Table USA OTC Drug Price by Type (2011-2016)
Figure USA OTC Drug Sales Growth Rate by Type (2011-2016)
Table USA OTC Drug Sales by Application (2011-2016)
Table USA OTC Drug Sales Market Share by Application (2011-2016)
Figure USA OTC Drug Sales Market Share by Application in 2015
Table USA OTC Drug Sales Growth Rate by Application (2011-2016)
Figure USA OTC Drug Sales Growth Rate by Application (2011-2016)
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare OTC Drug Sales Market Share (2011-2016)
Table GlaxoSmithKline (GSK) Basic Information List
Table GlaxoSmithKline (GSK) OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline (GSK) OTC Drug Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson OTC Drug Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer OTC Drug Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi OTC Drug Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca OTC Drug Sales Market Share (2011-2016)
Table BioGaia Basic Information List
Table BioGaia OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioGaia OTC Drug Sales Market Share (2011-2016)
Table Bristol Myers Squibb Basic Information List
Table Bristol Myers Squibb OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol Myers Squibb OTC Drug Sales Market Share (2011-2016)
Table Bukwang Pharmaceutica Basic Information List
Table Bukwang Pharmaceutica OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bukwang Pharmaceutica OTC Drug Sales Market Share (2011-2016)
Table Chr. Hansen Basic Information List
Table Chr. Hansen OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Chr. Hansen OTC Drug Sales Market Share (2011-2016)
Table Cipla Basic Information List
Table Cipla OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cipla OTC Drug Sales Market Share (2011-2016)
Table CoLucid Basic Information List
Table CoLucid OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table CoLucid OTC Drug Sales Market Share (2011-2016)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daiichi Sankyo OTC Drug Sales Market Share (2011-2016)
Table Dr. Reddy's Laboratories Basic Information List
Table Dr. Reddy's Laboratories OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dr. Reddy's Laboratories OTC Drug Sales Market Share (2011-2016)
Table DSM Basic Information List
Table DSM OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table DSM OTC Drug Sales Market Share (2011-2016)
Table Eisai Basic Information List
Table Eisai OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai OTC Drug Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly OTC Drug Sales Market Share (2011-2016)
Table EMS Basic Information List
Table EMS OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table EMS OTC Drug Sales Market Share (2011-2016)
Table Euradite Basic Information List
Table Euradite OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Euradite OTC Drug Sales Market Share (2011-2016)
Table Friggs Basic Information List
Table Friggs OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Friggs OTC Drug Sales Market Share (2011-2016)
Table Genomma Lab Internacional Basic Information List
Table Genomma Lab Internacional OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genomma Lab Internacional OTC Drug Sales Market Share (2011-2016)
Table Glanbia Basic Information List
Table Glanbia OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Glanbia OTC Drug Sales Market Share (2011-2016)
Table Herbalife Basic Information List
Table Herbalife OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Herbalife OTC Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of OTC Drug
Figure Manufacturing Process Analysis of OTC Drug
Figure OTC Drug Industrial Chain Analysis
Table Raw Materials Sources of OTC Drug Major Manufacturers in 2015
Table Major Buyers of OTC Drug
Table Distributors/Traders List
Figure USA OTC Drug Production and Growth Rate Forecast (2016-2021)
Figure USA OTC Drug Revenue and Growth Rate Forecast (2016-2021)
Table USA OTC Drug Production Forecast by Type (2016-2021)
Table USA OTC Drug Consumption Forecast by Application (2016-2021)
  • United States Hydroxyapatite (HA) Coatings Market Report 2017
    Published: 21-Jul-2017        Price: US 3800 Onwards        Pages: 97
    In this report, the United States Hydroxyapatite (HA) Coatings market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and gr......
  • 2017-2022 Philippines Vaginal Pessary Market Report (Status and Outlook)
    Published: 21-Jul-2017        Price: US 3360 Onwards        Pages: 111
    "This report will be delivered in 2-3 business days after the order is placed." The Vaginal Pessary market size will be XX million (USD) in 2022 in Philippines, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Malaysia market, the top players include CooperSurgical MedGyn Personal Medical Corp Integra LifeSciences Panpac ......
  • United States Orthopedic Implant Coatings Market Report 2017
    Published: 21-Jul-2017        Price: US 3800 Onwards        Pages: 101
    In this report, the United States Orthopedic Implant Coatings market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and gro......
  • United States Plasma Sprayed Coatings for Medical Use Market Report 2017
    Published: 21-Jul-2017        Price: US 3800 Onwards        Pages: 96
    In this report, the United States Plasma Sprayed Coatings for Medical Use market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market s......
  • EMEA (Europe, Middle East and Africa) Dalteparin Sodium Market Report 2017
    Published: 21-Jul-2017        Price: US 4000 Onwards        Pages: 111
    In this report, the EMEA Dalteparin Sodium market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Dalteparin Sodium for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; ......
  • EMEA (Europe, Middle East and Africa) Dialysate Market Report 2017
    Published: 21-Jul-2017        Price: US 4000 Onwards        Pages: 109
    In this report, the EMEA Dialysate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Dialysate for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Middle East: ......
  • 2017-2022 United States Vaginal Pessary Market Report (Status and Outlook)
    Published: 21-Jul-2017        Price: US 3360 Onwards        Pages: 111
    "This report will be delivered in 2-3 business days after the order is placed." The Vaginal Pessary market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In United States market, the top players include CooperSurgical MedGyn Personal Medical Corp Integra LifeSciences ......
  • United States DT-Based Combined Vaccines Market Report 2017
    Published: 21-Jul-2017        Price: US 3800 Onwards        Pages: 114
    In this report, the United States DT-Based Combined Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and grow......
  • Asia-Pacific Albumen Powder Market Report 2017
    Published: 21-Jul-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the Asia-Pacific Albumen Powder market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Albumen Powder for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs